Outcomes of Anticoagulation Therapy in Adults With Tetralogy of Fallot

Journal of the American Heart Association
Alexander C EgbeHeidi M Connolly

Abstract

Background Available outcomes data for anticoagulation therapy in adults with congenital heart disease ( CHD ) provide assessment of global risk of this therapy for CHD patients (a heterogeneous population), but the risk of complications for the different CHD diagnoses is unknown. The purpose of the study was to describe the indications for anticoagulation, and the incidence and risk factors for major bleeding complication in adults with tetralogy of Fallot. Methods and Results We queried Mayo Adult Congenital Heart Disease (MACHD) database for tetralogy of Fallot patients (aged ≥18 years) that received anticoagulation, 1990-2017. Of 130 patients (42±14 years, 75 men [58%]), warfarin and direct oral anticoagulants were used in 125 (96%) and 5 (4%), respectively because atrial arrhythmias (n=109), mechanical prosthetic valve (n=29), intracardiac thrombus (n=4), pulmonary embolism (n=6), stroke (n=3), and perioperative anticoagulation (n=44). The median hypertension, abnormal renal or liver function; stroke; bleeding history or predisposition; labile international normalized ratio; elderly (>65 years); drug or alcohol use score for the entire cohort was 1 (0-2) and 27 (21%) had hypertension, abnormal renal or liver function; stro...Continue Reading

References

Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Feb 28, 2009·Journal of the American College of Cardiology·Maurice Beghetti, Nazzareno Galiè
Aug 18, 2010·Circulation·Paul KhairyUNKNOWN Alliance for Adult Research in Congenital Cardiology (AARCC)
Aug 31, 2010·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Committee for Practice Guidelines (CPG)
Mar 1, 2012·Congenital Heart Disease·Julio SandovalCraig S Broberg
Dec 20, 2014·JACC. Cardiovascular Interventions·Jerrold H LevyJames Douketis
Jan 8, 2015·Heart·Jenna M FairclothGruschen R Veldtman
Jan 5, 2016·The American Journal of Cardiology·Claudia PujolHarald Kaemmerer
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Aug 31, 2016·International Journal of Cardiology·Paul KhairyUNKNOWN Anticoagulation Therapy in Congenital Heart Disease (TACTIC) investigators and the Alliance for Adult Research in Congenital
Sep 17, 2016·Journal of the American College of Cardiology·Alexander C EgbeDavid J Driscoll
Dec 17, 2016·American Heart Journal·Alexander C EgbeDavid J Driscoll
Feb 18, 2017·International Journal of Cardiology·Keita MasudaKazutaka Aonuma
Oct 27, 2017·The Canadian Journal of Cardiology·Darryl WanSantabhanu Chakrabarti

❮ Previous
Next ❯

Software Mentioned

JMP

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.